Curis
CRIS
#10225
Rank
NZ$26.38 M
Marketcap
NZ$2.04
Share price
-0.84%
Change (1 day)
-66.03%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.35. In 2024 the company made an earnings per share (EPS) of NZ-$12.16 an increase over its 2023 EPS that were of NZ-$15.62.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-47.52%
2024NZ-$12.16-22.15%
2023NZ-$15.62-26.17%
2022NZ-$21.1622.3%
2021NZ-$17.30-25.37%
2020NZ-$23.18-30.93%
2019NZ-$33.56-2.02%
2018NZ-$34.25
2016NZ-$77.84-10%
2015NZ-$86.49138.1%
2014NZ-$36.3340%
2013NZ-$25.95-25%
2012NZ-$34.6066.67%
2011NZ-$20.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
NZ$4.12-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.44-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.85-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.14-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.44 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA